Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 11:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 365 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obsessive Compulsive Disorder (OCD) Clear all

Conditions: Obsessive-Compulsive Disorder
Interventions: ExAblate MR-guided Focused Ultrasound Bilateral Anterior Capsulotomy; Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 25 Years to 64 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 2
States / cities: Palo Alto, California • Boston, Massachusetts

Conditions: Obsessive Compulsive Disorder
Interventions: sertraline, psychotherapy; Drug · Behavioral
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 6 Years to 16 Years
Enrollment: 941 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 44
States / cities: Dothan, Alabama • Imperial, California • Los Angeles, California + 39 more

Conditions: Alcoholism, Anxiety Disorders, Generalized Anxiety Disorder, Post-Traumatic Stress Disorder, Panic Disorder, Obsessive-Compulsive Disorder
Interventions: Seroquel XR; Drug
Lead sponsor: Creighton University; Other
Eligibility: 19 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Obsessive-Compulsive Disorder
Interventions: No Intervention; Other
Lead sponsor: ProgenaBiome; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Ventura, California

Conditions: Obsessive-compulsive Disorder, Social Phobia, Generalized Anxiety Disorder, Specific Phobia, Separation Anxiety Disorder, Selective Mutism, Anxiety Disorder, Not Otherwise Specified
Interventions: Parent-Led Exposure Therapy, Treatment As Usual; Behavioral · Other
Lead sponsor: University of South Florida; Other
Eligibility: 3 Years to 7 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Skin-Picking, Trichotillomania (Hair-Pulling Disorder)
Interventions: Memantine, ComB Behavioral Therapy; Drug · Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Schizophrenia OCD, Obsessive Compulsive Disorder
Interventions: Aripiprazole; Drug
Lead sponsor: Jamaica Hospital Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Jamaica, New York

Conditions: OCD
Interventions: ERP for Individuals; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Trichotillomania, Hair Pulling Disorder
Interventions: Milk Thistle, Placebo; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 10 Years to 65 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Trichotillomania
Interventions: Comprehensive Behavior Modification, Attention; Behavioral
Lead sponsor: American University; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Obsessive Compulsive Disorder
Interventions: Cognitive Control Training, Peripheral Vision Task; Behavioral
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obsessive-Compulsive Disorder
Interventions: Exposure and Ritual Prevention (Cognitive Behavioral Therapy), Stress Management Therapy (Cognitive Behavior Therapy); Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2007
U.S. locations: 2
States / cities: New York, New York • Philadelphia, Pennsylvania

Conditions: Bipolar Affective Disorders, Cyclothymic Disorder, Schizoaffective Disorder, Major Depressive Disorder, Dysthymic Disorder, Obsessive-Compulsive Disorder, Panic Disorder, Posttraumatic Stress Disorder, Premenstrual Dysphoric Disorder, Social Anxiety Disorder
Interventions: Not listed
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Obsessive-Compulsive Disorder
Interventions: Dorsal medial Prefrontal Cortex intermittent theta burst stimulation, cTBS to ROFC; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 13 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obsessive-Compulsive Disorder
Interventions: Individual Child CBT, Positive Family Interaction Therapy; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 8 Years to 17 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obsessive-compulsive Disorder (OCD)
Interventions: Psilocybin 100 mcg/kg, Psilocybin 300 mcg/kg, Lorazepam 1 mg; Drug
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Obsessive-Compulsive Disorder, Post Traumatic Stress Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder
Interventions: Exposure-Based Therapy; Behavioral
Lead sponsor: Jasper A. Smits; Other
Eligibility: 18 Years to 70 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 2
States / cities: Boston, Massachusetts • Austin, Texas

Conditions: Trichotillomania
Interventions: StopPulling.com; Behavioral
Lead sponsor: American University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Obsessive-Compulsive Disorder
Interventions: Summit RC+S System, One Month Blinded Discontinuation Period:; Device · Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 21 Years to 70 Years
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 3
States / cities: Pittsburgh, Pennsylvania • Providence, Rhode Island • Houston, Texas

Conditions: Obsessive Compulsive Disorder
Interventions: Duloxetine; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Compulsive Behavior, Obsessive-Compulsive Disorder
Interventions: Habit Override Practice, Transcranial Magnetic Stimulation, Sham Training, Sham Transcranial Magnetic Stimulation; Behavioral · Device
Lead sponsor: Rebecca Price; Other
Eligibility: 18 Years to 60 Years
Enrollment: 203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Obsessive Compulsive Disorder
Interventions: St. John's Wort; Drug
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2003
U.S. locations: 2
States / cities: Oklahoma City, Oklahoma • Madison, Wisconsin

Conditions: Obsessive-Compulsive Disorder
Interventions: Ketamine, Midazolam; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: Obsessive Compulsive Disorder, Major Depressive Disorder, Anxiety
Interventions: Not listed
Lead sponsor: University of Florida; Other
Eligibility: 8 Years to 20 Years
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Gainesville, Florida

Search by objective public record fields.

Sonication-based OCD Neurosurgical Intervention Via Capsulotomy

Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)

Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obsessive-Compulsive Disorder

Brief Behavioral Treatment for Anxiety in Young Children

Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors

Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)

Individual Versus Group Exposure With Response Prevention (ERP) for the Treatment of Obsessive Compulsive Disorder (OCD)

Milk Thistle in Trichotillomania in Children and Adults

Comprehensive Behavioral (ComB) Model of Treatment for Trichotillomania

Assessing the Effects of a Neurobehavioral Intervention on Symptoms of Obsessive Compulsive Disorder

Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder

The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels

Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation

Family Focused Treatment of Pediatric Obsessive Compulsive Disorder

Psilocybin for Treatment of Obsessive Compulsive Disorder

CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy

Stepped Care in the Treatment of Trichotillomania

Development of Adaptive Deep Brain Stimulation for OCD

Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)

Theta Burst Stimulation Plus Habit Override Training for Compulsive Behaviors

St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder.

Understanding How Ketamine Brings About Rapid Improvement in OCD

Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic